Duearity AB Total Liabilities
Duearity AB total liabilities. Based on the latest financial reports, Duearity AB (DEAR) has total liabilities worth Skr22.38 Million SEK (≈ $2.41 Million USD) as of June 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See DEAR days of operational coverage to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Duearity AB (2020–2023)
Total liabilities of Duearity AB from 2020 to 2023. This chart illustrates how Duearity AB's total liabilities have evolved over time, based on quarterly financial data.
Duearity AB Competitors by Total Liabilities
The table below lists competitors of Duearity AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Southstone Minerals Ltd
V:SML
|
Canada | CA$6.07 Million |
|
Krakchemia SA
WAR:KCH
|
Poland | zł81.52 Million |
|
Eden Research plc
LSE:EDEN
|
UK | GBX2.85 Million |
|
Tortilla Mexican Grill PLC
LSE:MEX
|
UK | GBX56.74 Million |
|
Challenger Energy Group PLC
LSE:CEG
|
UK | GBX13.66 Million |
|
Blaize Holdings, Inc. Warrants
NASDAQ:BZAIW
|
USA | $63.24 Million |
|
Profusa, Inc. Common Stock
NASDAQ:PFSA
|
USA | $29.06 Million |
Liability Composition Analysis (2020–2023)
This chart breaks down Duearity AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Duearity AB's balance sheet.
Liquidity & Leverage Metrics
Duearity AB Total Liabilities Ratios Explained
Duearity AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.94 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Duearity AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Duearity AB (2020–2023)
The table below shows the annual total liabilities of Duearity AB from 2020 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | Skr17.53 Million ≈ $1.89 Million |
+192.56% |
| 2022-12-31 | Skr5.99 Million ≈ $644.83K |
+18.73% |
| 2021-12-31 | Skr5.05 Million ≈ $543.12K |
+762.71% |
| 2020-12-31 | Skr585.00K ≈ $62.96K |
-- |
About Duearity AB
Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help pe… Read more